8 Federal Pharmacy Compliance Practice Cases

Federal requirements and practice

These cases apply selected federal requirements to pharmacy practice. State law, payer rules, and a drug’s specific program requirements may impose additional or stricter obligations, so check them before acting. DEA and FDA guidance can help explain requirements, but applicable statutes and regulations control.

Across these situations, document decisions and actions. For controlled substances, confirm that the prescription is valid and the requested transaction is permitted for its schedule; for recalls, prevent further dispensing of affected product and follow the notice; for REMS drugs, complete the specific program’s requirements before dispensing.

Schedule II prescriptions

A patient requests a refill of a Schedule II medication, but the prescription record shows no refills remaining. Even if the patient says the prescriber intended to authorize more, do not dispense the medication as a refill. Contact the prescriber for a new, valid prescription if continued treatment is intended.

A Schedule II prescription cannot be refilled under federal law. The patient’s report does not change the prescription on file or create refill authorization. Keep the prescription and any required communications in the pharmacy’s records.

Controlled-substance discrepancies

If a closing count shows that the Schedule II inventory is short by several units and the cause is not immediately clear, secure the stock and records, promptly investigate and document the discrepancy, and notify appropriate pharmacy leadership.

Assess whether the event is a theft or significant loss. If it is, federal rules require reporting to DEA and submission of DEA Form 106; follow DEA reporting procedures and applicable timelines. Do not assume every small unexplained discrepancy has the same reporting outcome. Document the facts and make the determination promptly.

Controlled-substance recordkeeping and security help detect diversion. The applicable regulations govern federal requirements.

Drug recalls and affected lots

When a recall notice identifies a particular lot, compare the notice with the product and lot numbers on hand. Quarantine matching stock so it cannot be dispensed, follow the recall instructions for its return or other disposition, and document the actions taken.

Use dispensing records to identify potentially affected patients, then follow the notice’s directions for communication and coordination with prescribers. If records cannot distinguish the lot, seek guidance from the manufacturer and relevant health authorities rather than assuming no patients were affected.

Interpreting recall classes

FDA recall classes describe relative health risk:

• Class I: A reasonable probability of serious harm or death.

• Class II: Possible temporary or medically reversible harm, or a remote probability of serious harm.

• Class III: Unlikely to cause adverse health consequences.

A recall’s class informs urgency, but the pharmacy should follow the specific notice and applicable instructions.

REMS requirements before dispensing

If a prescription is for a medication whose REMS requires the pharmacy to be certified and to verify specified safe-use conditions, do not dispense until the applicable requirements have been met and the required verification is complete. If information is missing, contact the REMS program, prescriber, or patient as appropriate to resolve it, and document the steps taken.

Depending on the program, requirements may include pharmacy certification and procedures to verify prescriber certification, patient enrollment, testing, or other safe-use conditions before dispensing. Requirements vary by medication and program; consult that drug’s current REMS materials rather than relying on a general checklist.

• drug recall